Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Donanemab shows promise in slowing Alzheimer's disease

Donanemab shows promise in slowing Alzheimer's disease

Are antidrug antibodies reducing the effectiveness of rheumatoid arthritis treatment?

Are antidrug antibodies reducing the effectiveness of rheumatoid arthritis treatment?

Researcher receives $2.7 million grant to study lingering Lyme disease symptoms

Researcher receives $2.7 million grant to study lingering Lyme disease symptoms

COVID antiviral treatments underused in nursing homes, study finds

COVID antiviral treatments underused in nursing homes, study finds

New drug could overcome resistance to CDK4/6 inhibitors in breast cancer

New drug could overcome resistance to CDK4/6 inhibitors in breast cancer

Difficult transmembrane protein targets for therapeutic antibodies

Difficult transmembrane protein targets for therapeutic antibodies

AGS supports CMS decision to require registry data for monoclonal antibodies for Alzheimer's disease

AGS supports CMS decision to require registry data for monoclonal antibodies for Alzheimer's disease

mAb-based bELISA developed to detect SARS-CoV-2 antibodies in a broad spectrum of animal species

mAb-based bELISA developed to detect SARS-CoV-2 antibodies in a broad spectrum of animal species

Scientists develop cross-species coronavirus test

Scientists develop cross-species coronavirus test

Advances in influenza research

Advances in influenza research

Understanding the biological effects of SARS-CoV-2 persistence in children

Understanding the biological effects of SARS-CoV-2 persistence in children

New study offers clues on how to future-proof covid-19 vaccines

New study offers clues on how to future-proof covid-19 vaccines

Viral clearance: A potential predictor of COVID-19 treatment efficacy

Viral clearance: A potential predictor of COVID-19 treatment efficacy

Treatment with dupilumab leads to sustained improvements in COPD patients with type 2 inflammation

Treatment with dupilumab leads to sustained improvements in COPD patients with type 2 inflammation

Battle against RSV: Computational design paves way for new polyvalent vaccine

Battle against RSV: Computational design paves way for new polyvalent vaccine

Broader search needed for successful management of eosinophilic gastritis

Broader search needed for successful management of eosinophilic gastritis

PREACH-M trial: Lenzilumab may improve treatment response in chronic myelomonocytic leukemia

PREACH-M trial: Lenzilumab may improve treatment response in chronic myelomonocytic leukemia

Study shows how blood makes the brain’s immune cells toxic

Study shows how blood makes the brain’s immune cells toxic

SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

MFAP5, a microfibril-associated protein, unveiled as key player in scar formation and wound healing

MFAP5, a microfibril-associated protein, unveiled as key player in scar formation and wound healing

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.